Searching for “”
We have found 918 results for your search term.
CUTISS AG successfully raises CHF 25M in Series C funding round
Our alumni project, denovoSkin (now known as CUTISS AG) has successfully closed its first CHF 25 million in its Series C funding round. This first closing allows CUTISS to enter Phase 3 clinical...
Tandem Therapeutics AG and Project Tethys shortlisted in the Top 10 De Vigier Awards
W.A. De Vigier has announced the shortlist of the top 10 startups. Tandem Therapeutics AG and Tethys have made it to the shortlist
Voliro AG is announced as winner at the Swiss Economic Awards 2024
The Swiss Economic Award recognizes outstanding entrepreneurial achievements in the categories of "Services", "Deeptech/Lifesciences" and "Production/Trade".
CASE BioMed and Wyss Zurich announce collaboration
The Center of Advanced Studies on Entrepreneurship in BioMedicine (CASE BioMed) at the Università della Svizzera italiana (USI) and the Wyss Zurich Translational Center (Wyss Zurich) have signed a...
Cellerys AG announces start of immune tolerance trial RED4MS trial in multiple sclerosis
This important trial will be conducted in 4 countries across Europe and aims to demonstrate the power of immune tolerizing approaches for patients with multiple sclerosis.
Tandem Therapeutics AG wins at De Vigier Awards
On 19 June, 10 selected startups took the stage to once again pitch their projects. Six winners were selected including Tandem Therapeutics AG led by Mamta Chabria.
Tailor-Made Stem Cells
In a few years, we’re likely to see personalized stem cells being used in the first clinical trials for heart patients. But there are still a few hurdles to overcome on the way from the lab to the...
Reconstructive skin surgery: positive Phase 2 interim analysis on efficacy for denovoSkin™ in pediatric, adolescent and adult patients
Our alumni project, denovoSkin (aka CUTISS), has announced positive interim analysis on efficacy from the Phase 2 clinical trial of its lead product denovoSkin™ in patients undergoing...